Jose Carlos Plaza-Hernandez
Overview
Explore the profile of Jose Carlos Plaza-Hernandez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
2
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Bravo L, Villegas A, Lopez Uceda B, Mariscal A, Vadillo C, Nieto Barbero M, et al.
Heliyon
. 2025 Feb;
11(2):e41311.
PMID: 39906838
Cumulative evidence suggests a link between specific autoimmune diseases (AD), including idiopathic inflammatory myopathies (IIM), and SARS-CoV-2 infection or COVID-19 vaccination. Anti-synthetase syndrome (ASS), a subset of IIM, is defined...
2.
Cabezas-Camarero S, Iglesias-Moreno M, Cerezo Druet E, Sotelo M, Merino-Menendez S, Cabrera-Martin M, et al.
Anticancer Drugs
. 2024 Apr;
35(5):481-482.
PMID: 38567818
No abstract available.
3.
Cabezas-Camarero S, Iglesias-Moreno M, Cerezo Druet E, Sotelo M, Merino-Menendez S, Cabrera-Martin M, et al.
Anticancer Drugs
. 2023 Feb;
34(5):695-698.
PMID: 36730545
Up to 10-15% of patients with first-line recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) present with platinum-refractory disease. The anti-PD1 nivolumab is the first therapeutic option in this...
4.
Cabezas-Camarero S, Merino-Menendez S, Cabrera-Martin M, Sotelo M, Plaza-Hernandez J, Falahat F, et al.
Oncol Lett
. 2023 Jan;
25(1):37.
PMID: 36589672
Novel chemo-immunotherapy (chemo-IO) combinations should be evaluated, which may be suitable for cisplatin-unfit or fluoropyrimide-ineligible patients with recurrent or metastatic squamous cell carcinoma of head and neck (R/M SCCHN) to...
5.
Cabezas-Camarero S, Alonso-Ovies A, Merino-Menendez S, Cabrera-Martin M, Plaza-Hernandez J, Perez-Segura P
Oral Oncol
. 2021 Nov;
123:105589.
PMID: 34742008
Head and neck cancers are increasingly being diagnosed in elderly patients, where standard curative-intent, therapeutic options are often too aggressive for frail, malnourished and heavily comorbid patients. Since the incorporation...